Related Experiment Video
Updated: Jul 28, 2026

Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography
Published on: December 27, 2024
Safety aspects of vitamin A administration
1Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232-0146, USA.
Insights
Vitamin A supplementation is safe for premature infants and young children, including those with respiratory syncytial virus (RSV). Proper administration can improve vitamin A levels and potentially reduce illness.
Area of Science:
- Nutritional Science
- Pediatric Medicine
- Virology
Background:
- Vitamin A deficiency is a concern in vulnerable infant populations.
- Respiratory Syncytial Virus (RSV) infection poses significant risks to young children.
- Previous research has explored vitamin A's role in infant health.
Purpose of the Study:
- To review the established safety of vitamin A therapy in premature neonates.
- To evaluate the recent use of vitamin A in children with RSV infections.
- To assess the therapeutic potential of vitamin A in pediatric populations.
Main Methods:
- Review of studies involving vitamin A (retinyl palmitate) administration.
- Focus on neonates and infants with documented low blood retinol levels.
- Analysis of safety and efficacy data from clinical interventions.
Main Results:
- Vitamin A administration was found to be safe in neonates and infants.
- No significant acute toxic effects were observed.
- Evidence suggests safe therapeutic use in targeted pediatric groups.
Conclusions:
- Carefully controlled vitamin A administration can safely improve vitamin A status.
- Elevated blood vitamin A levels may contribute to reduced morbidity.
- Vitamin A therapy shows promise for improving health outcomes in infants and children.
Objective:
To review longstanding experience in the safe use of vitamin A as therapeutic agent in prematurely born human neonates and more recently with young children infected with the respiratory syncytial virus (RSV).
Design:
The studies reviewed were designed to intervene with vitamin A in the form of retinyl palmitate in human neonates and infants showing low levels of retinol in the blood.
Setting:
Vanderbilt University School of Medicine.
Results:
Evidence is presented that vitamin A can be administered safely to human neonates and infants without apparent acute toxic effects.
Conclusion:
A carefully designed mode of administration of vitamin A can improve a patient's vitamin A status as determined by the elevation of blood vitamin A levels which in turn may be beneficial in lowering the morbidity.
Related Concept Videos
Factors Affecting Drug Response: Overview
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Vitamins
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Drug Toxicity: Risk factors
